Rezum uses thermal energy from water vapor to shrink excess prostate tissue, restoring normal urinary function without major side effects.

A specialized device is inserted through the urethra to deliver controlled bursts of sterile water vapor directly into the enlarged prostate tissue.

As the vapor disperses, it releases stored thermal energy, effectively damaging and killing excess prostate cells while sparing surrounding healthy tissue.

Over the next few weeks, the body’s natural healing process kicks in, gradually absorbing and eliminating the treated prostate tissue. This reduction in prostate size relieves pressure on the urethra, improving urinary flow and reducing symptoms such as urgency, frequency, weak stream, and nighttime urination.

The UroLift procedure is a minimally invasive surgical treatment for benign prostatic hyperplasia (BPH) that involves using a device to lift and hold enlarged prostate tissue out of the way, thereby opening the blocked urethra without cutting, heating, or removing tissue.

The procedure uses permanent, tiny implants to secure the prostate tissue, resulting in a quicker recovery and no impact on sexual function, including retrograde ejaculation. It's an option for men with symptomatic BPH who want to avoid medication or more invasive surgery.

he iTind™ device is placed within the prostatic urethra in a folded configuration. Once in place, the iTind device expands and its struts exert longitudinal force on the prostatic urethra and the bladder neck at the 12, 5 and 7 o’clock positions.

Over the course of 5 to 7 days, through continuous ischemic pressure and subsequent tissue necrosis and scarring, deep longitudinal channels are created through which urine can flow freely.

After 5-7 days, the iTind device is completely removed during an in-office procedure. The newly formed channels continue to provide sustained relief over the long-term as demonstrated in published clinical studies out to 4 years.